These partnerships demonstrate the many ways that companies find strength in numbers throughout the subsegments, creating a stronger industry as a whole.
Companies spoke about the need for navigation, robotics and AI at NASS 2024.
Outpatient surgery is the vanguard of modern healthcare and the future of surgical and medical innovation, says an ASC investor.
Masmec has developed advanced surgical navigation systems, AI, and high-complexity medical technologies with application in spinal and trauma procedures.
The sub-component technology, which lets robotics and navigation manufacturers build robots that see what surgeons see, is now ready for partners to integrate.
Developed for physician-led organizations, health systems, and ASC operators, the integrated platform is designed to simplify ASC development, accelerate facility readiness, and support long-term operational success.
The transaction could combine MicroPort’s joint replacement products and overseas channels with Tinavi’s orthopedic robotics capabilities.
Expanding Innovations’ technology will complement the DePuy Synthes TriALTIS Spine System and be integrated into the VELYS Enabling Tech portfolio for spine.
VB Spine intends to make CT-Fluoro technology available as part of its technology offerings for spine procedures.
OrthoPediatrics will exclusively provide OSSIO orthopedic fixation technology to U.S. children’s hospitals throughout the U.S.
The Master Service Agreement will expand distribution of VB Spine products into Mexico.
Gemtrack tracking technology, developed by MinMaxMedical, will be developed for use across DePuy’s joint replacement portfolio for navigation and robotic applications.
The partnership covers the bone graft substitute + growth factors, across DePuy’s CMF, spine, and trauma portfolio and is exclusive in the U.S., Canada and Australia.
OSSIO is ready to take the next step in its evolution. With a new U.S. headquarters and pipeline of products, it’s primed for growth.
Nathan Folkert is joining the company later in May, replacing Craig Gaffin who will be leaving Smith+Nephew to pursue a new opportunity.
Stryker, Carlsmed and THINK Surgical are recipients of the 2026 awards, which celebrate advancements shaping the future of orthopedic manufacturing, device performance and patient care.
The transaction was completed by Osartis, a Demetra Group company, which has acquired 100% ownership and full control of Maxxspine Innovative, effective as of today.
The collaboration will offer enhanced access to the bone growth accelerator, along with enhanced savings for PearlMatrix to Vizient clients.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.
